Earnings Feed
Start Free
Home/Insiders/MELDRUM PETER D
MP
SEC Insider//CIK 0001008310

MELDRUM PETER D

CIK 00010083102 companiesSALT LAKE CITY, UT
SEC Profile

Transactions

50

Companies

2

Filings

7

CIK

0001008310

Recent Transactions

50 trades
  • Award
    ENDOCYTE INC

    Common Stock

    2017-05-04+3,300→ 7,800 total
  • Award
    ENDOCYTE INC

    Stock Option (right to buy)

    2017-05-04+19,500→ 19,500 total
  • Award
    ENDOCYTE INC

    Common Stock

    2016-05-05+2,250→ 4,500 total
  • Award
    ENDOCYTE INC

    Stock Option (right to buy)

    2016-05-05+13,500→ 13,500 total
  • Award
    ENDOCYTE INC

    Stock Option (right to buy)

    2015-05-14+13,500→ 13,500 total
  • Award
    ENDOCYTE INC

    Common Stock

    2015-05-14+2,250→ 2,250 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Incentive Stock Option (right to buy)

    2015-05-06−5,555→ 0 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2015-05-06$18.00/sh+5,555→ 10,424 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Incentive Stock Option (right to buy)

    2014-11-05−1→ 0 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-11-05$16.53/sh+1→ 10,869 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-11-05$23.11/sh+4,328→ 10,868 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Incentive Stock Option (right to buy)

    2014-11-05−4,328→ 0 total
  • Gift
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-11-03−6,000→ 540 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-07-14$9.04/sh+24,000→ 30,540 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-07-14−24,000→ 48,000 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-07-14$39.50/sh−24,000→ 6,540 total
  • Gift
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-04-04−8,544→ 6,540 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-03-19$30.12/sh+55,000→ 81,084 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-03-19−55,000→ 107,654 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-03-19$37.00/sh−55,000→ 26,084 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-03-17$30.12/sh+55,000→ 81,084 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-03-17−55,000→ 162,654 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-03-17$35.15/sh−55,000→ 26,084 total
  • Gift
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-12−29,572→ 26,084 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$30.78/sh−9,040→ 55,656 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$30.78/sh−51,096→ 55,656 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-02-05−51,096→ 0 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$8.63/sh+31,804→ 87,460 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$30.78/sh−31,804→ 55,656 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$7.82/sh+9,040→ 64,696 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-02-05−9,040→ 0 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$7.27/sh+51,096→ 106,752 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$8.63/sh+32,000→ 87,656 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-02-05−31,804→ 0 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-02-05$32.00/sh−32,000→ 55,656 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2014-02-05−32,000→ 31,804 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-11-08$5.89/sh+20,000→ 75,656 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2013-11-08−11,784→ 0 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-11-08$6.00/sh+11,784→ 67,440 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-11-08$26.52/sh−20,000→ 55,656 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-11-08$26.46/sh−11,784→ 55,656 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2013-11-08−20,000→ 0 total
  • Gift
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-11-07−502→ 55,656 total
  • Gift
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-11-06−30,000→ 56,158 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Incentive Stock Option (right to buy)

    2013-09-17+3,775→ 3,775 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2013-09-17+566,225→ 566,225 total
  • Award
    ENDOCYTE INC

    Stock Option (right to buy)

    2013-06-19+14,000→ 14,000 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-05-14$7.82/sh+15,000→ 100,312 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2013-05-14$34.00/sh−15,000→ 85,312 total
  • Exercise/Conversion
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2013-05-14−15,000→ 9,040 total

Companies

2

Recent Filings

7

Address

320 WAKARA WAY

SALT LAKE CITY, UT, 84108

View on SEC.gov